1. AB0388 Results at 3 years of an optimization guideline of biological therapies in rheumatoid arthritis. create record results. (15th June 2017) Authors: Font, P; Castro, MC; Romero, M; Ortega, R; Calvo, J; Ruiz, D; Cardenas, M; Alejandre, R; Carreto, P; Collantes, E Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1184 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0431 Altered expression of circulating micrornas is related to disease activity and structural damage in ankylosing spondylitis patients. (15th June 2017) Authors: Font, P; Perez-Sanchez, C; Ruiz-Limon, P; Lopez-Pedrera, C; Castro-Villegas, MC; Άbalos-Aguilera, MC; Barbarroja, N; Rosa, I Arias-de la; Lopez-Montilla, MD; Escudero-Contreras, A; Lopez-Medina, C; Collantes-Estevez, E; Jimenez-Gomez, Y Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 649 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 4CPS-118 Real clinical impact of drug–drug interactions of immunosuppressants in transplant patients. (24th March 2020) Authors: Gago-Sanchez, AI; Cardenas, M; Aumente, MD; Font, P; Del Prado, JR; Calleja, MA Journal: European journal of hospital pharmacy Issue: Volume 27(2020)Supplement 1 Page Start: A102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. CP-078 Optimisation of biological therapy in established rheumatoid arthritis patients in real life clinical practice. (14th February 2016) Authors: Cárdenas, M; Font, P; De la Fuente, S; Castro-Villegas, MC; Romero-Gómez, M; Ruiz-Vílchez, D; Escudero, A; Ortega-Castro, R; Calvo-Gutiérrez, J; Collantes-Estévez, E Journal: European journal of hospital pharmacy Issue: Volume 23(2016)Supplement 1 Page Start: A34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. FRI0429 Dysregulation of the splicing machinery in leukocytes from ankylosing spondylitis patients is associated to disease pathogenesis. (15th June 2017) Authors: Jimenez-Gomez, Y; Lopez-Pedrera, C; Pedraza-Arévalo, S; del, M Río-Moreno; Άbalos-Aguilera, MC; Ruiz-Limon, P; Perez-Sanchez, C; Castro, MC; Barbarroja, N; Rosa, I Arias-de la; Font, P; Escudero, A; Castaño, JP; Luque, RM; Collantes-Estevez, E Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 648 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. THU0236 Undifferentiated connective tissue disease: outcome of 40 patients. (1st June 2001) Authors: Romero, M; Aguirre, MA; Cisnal, A; Font, P; Cuadrado, MJ; Martinez, FG; Gonzalez, J; Escudero, A; Perez, V; Castro, C; Muñoz-Villanueva, MC; Collantes, E Journal: Annals of the rheumatic diseases Issue: Volume 60(2001)Supplement 1 Page Start: A301 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. SAT0410 Hla-b27 role in ankylosing spondylitis phenotype: results from the regisponser database. (15th June 2017) Authors: Arevalo, M; Font, P; Moreno, M; Ruiz, D; Castro, M; Carreto, P; Larrosa, M; Collantes, E; Gratacόs, J Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 926 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. CP-061 Long-term cost-effectiveness analysis of infliximab, etanercept and adalimumab in rheumatoid arthritis patients in real-life clinical practice. (24th March 2015) Authors: Cardenas, M; Font, P; De La Fuente-Ruiz, S; Viguera-Guerra, I; Casado, M; Castro-Villegas, M; Calvo-Gutierrez, J; Collantes-Estevez, E Journal: European journal of hospital pharmacy Issue: Volume 22(2015)Supplement 1 Page Start: A24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗